Clinical Study of SM3321 With Solid Tumors

NCT06087770 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG: SM3321

Sponsor

Beijing StarMab Biomed Technology Ltd